In an exciting turn of events in the biotech industry, Fate Therapeutics, a leading biopharmaceutical company, is set to grace the EULAR 2025 Congress in Barcelona, Spain with a detailed presentation of their clinical and preclinical data. This will cast a spotlight on their groundbreaking off-the-shelf cell therapy platform, which is centered around induced pluripotent […]